Evidence map›Paper›PMID 34114124›Full record

ReviewMolecular biology reports2021

Genetically modified crop regulations: scope and opportunity using the CRISPR-Cas9 genome editing approach.

Shweta Gupta, Adarsh Kumar, Rupali Patel, Vinay Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Knockout ofInternational journal of molecular sciences · 2024
    Article
  11. Advancements in genetic studies of mushrooms: a comprehensive review.World journal of microbiology & biotechnology · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shweta GuptaDepartment of Botany, School of Biological Sciences, Central University of Punjab, Ghudda, Bathinda, 151401, India.
Adarsh KumarDepartment of Botany, School of Biological Sciences, Central University of Punjab, Ghudda, Bathinda, 151401, India.
Rupali PatelDepartment of Botany, School of Biological Sciences, Central University of Punjab, Ghudda, Bathinda, 151401, India.
Vinay KumarDepartment of Botany, School of Biological Sciences, Central University of Punjab, Ghudda, Bathinda, 151401, India. vinayihbt@gmail.com.ORCID http://orcid.org/0000-0003-0077-0956

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global demand for food is increasing day by day due to an increase in population and shrinkage of the arable land area. To meet this increasing demand, there is a need to develop high-yielding varieties that are nutritionally enriched and tolerant against environmental stresses. Various techniques are developed for improving crop quality such as mutagenesis, intergeneric crosses, and translocation breeding. Later, with the development of genetic engineering, genetically modified crops came up with the transgene insertion approach which helps to withstand adverse conditions. The process or product-focused approaches are used for regulating genetically modified crops with their risk analysis on the environment and public health. However, recent advances in gene-editing technologies have led to a new era of plant breeding by developing techniques including site-directed nucleases, zinc finger nucleases, and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9) that involve precise gene editing without the transfer of foreign genes. But these techniques always remain in debate for their regulation status and public acceptance. The European countries and New Zealand, consider the gene-edited plants under the category of genetically modified organism (GMO) regulation while the USA frees the gene-edited plants from such type of regulations. Considering them under the category of GMO makes a long and complicated approval process to use them, which would decrease their immediate commercial value. There is a need to develop strong regulatory approaches for emerging technologies that expedite crop research and attract people to adopt these new varieties without hesitation.

Indexed as

CRISPR-Cas SystemsCrops, AgriculturalGovernment RegulationPlants, Genetically ModifiedClustered Regularly Interspaced Short Palindromic RepeatsGene EditingGenetic EngineeringGenome, PlantPlant BreedingTransgenesGenome editingGM cropsProcess-based regulationProduct-based regulationsgRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.